MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

489149

Report Date :

05.02.2018

 

 

IDENTIFICATION DETAILS

 

Name :

VASUDHA PHARMA CHEM LIMITED

 

 

Registered Office :

78/A, Vengalrao Nagar, Hyderabad – 500038, Telangana

Tel. No.:

91-40-44763666/ 23711717/ 23812046/ 23811576

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

20.12.1994

 

 

Com. Reg. No.:

36-019021

 

 

Capital Investment / Paid-up Capital :

INR 350.000 Million

 

 

CIN No.:

[Company Identification No.]

U24230TG1994PLC019021

 

 

IEC No.:

0995005621

 

 

TIN No.:

37390187262

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDV02144C

 

 

GSTIN :

36AAACV9857D1Z1

 

 

PAN No.:

[Permanent Account No.]

AAACV9857D

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Active Pharmaceutical Ingredients and Pharma Intermediates. [Registered Activity and also confirmed by management]

 

 

No. of Employees :

2000 (Approximately)

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 7800000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was established in the year 1994 and is engaged in manufacturing pharmaceutical ingredients. Its products include pipes done and piper dine derivatives.

 

Management has failed to file its latest financials with Government Registry.

 

As per available financials of March 2016, the company has registered growth pf 10.80% in its revenue as compared to its previous year’s revenue and reported good profit margins of 10.94% under review.

 

Rating takes into consideration the company’s established track record of business operations marked by healthy net worth base along with strong debt coverage indicators and good liquidity position.

 

Rating also takes into account the extensive industry experience of promoters and long standing relationship with its customer.

 

However, rating strength is partially offset by prevailing uncertain regulatory environment in the Indian pharma industry and ever increasing competition.

 

Payments seems to be regular.

 

In view of aforesaid, the company can be considered good for business dealings at usual trade terms and condition.

 

Note:

As per indirect sources, we could find that the company has achieved net sales were INR 5128.000 Million in the FY 2016 and INR 4625.000 Million in the FY 2015 and profit after tax was INR 561.000 Million in the FY 2016 and INR 509.000 Million in the FY 2015.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

INDIA RATING

Rating

Long Term Rating = A

Rating Explanation

Adequate degree of safety and low credit risk

Date

March, 2017

 

Rating Agency Name

INDIA RATING

Rating

Short Term Rating = A1+

Rating Explanation

Very strong degree of safety and carry lowest credit risk

Date

March, 2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 05.02.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Kumar

Designation :

Finance Manager

Contact No.:

91-40-44763666

Date :

02.02.2018

 

Name :

Mr. Gupta 

Designation :

Not Divulged

Contact No.:

91-40-44763666 / Ex-413

Date :

02.02.2018

 

 

LOCATIONS

 

Registered Office :

78/A, Vengalrao Nagar, Hyderabad – 500038, Telangana, India

Tel. No.:

91-40-44763666/ 23711717/ 23812046/ 23811576

Mob No.:

91-9441552555 (Mr. Arvind Rao)

Fax No.:

91-40-23706696/ 23811576/ 44763636

E-Mail :

legal@vasudhapharma.com

vasudha@vasudhapharma.com

Website :

www.vasudhapharma.com

Location :

Rented

Locality :

Commercial

 

 

Unit I:

Plot No. 39, A and B, Phase I, I.D.A, Jeedimetla, Hyderabad - 500055
Telangana, India

 

 

Unit II:

 

Plot No. 79, Jawaharlal Nehru Pharma City, Parawada, District Vishakhapatnam - 531021, Telangana, India

 

 

Unit III:

 

Plot No. 23 and 24, Jawaharlal Nehru Pharma City, Parawada, District Vishakhapatnam - 531021, Telangana, India

 

 

Unit IV:

Plot No. 01, Jawaharlal Nehru, Pharmacity, Parawada, District Vishakhapatnam – 531021, Andhra Pradesh, India

 

 

Branch Office :

  • Plot No. 184, Industrial Park, Opposite Jawaharlal Nehru Pharma City, Thanam Village, Parawada Mandal, Vishakhapatnam – 531021, Andhra Pradesh, India
  • Unit 2, Plot No. 79, Jawaharlal Nehru Pharma City, Parawada, Vishakhapatnam – 531021, Andhra Pradesh, India
  • Unit 3, Plot No. 23 and 24, Jawaharlal Nehru Pharma City, Parawada, Vishakhapatnam – 531021, Andhra Pradesh, India
  • Unit 4, Plot No. 01, Jawaharlal Nehru Pharma City, Thadi Village Parawada, Vishakhapatnam – 531019, Andhra Pradesh, India
  • Unit 1, Plot No. 39 A and B, IDS Jeedimetla, Rangareddy, Telangana – 500055, Hydrabad, India
  • Plot No. 42 and 43, Saibaba Nagar Colony, Kukatpally, Hyderabad - 500072, Rangareddy, Telangana, India
  • R and D Building, Commercial Hub, Road No. 13, Jawaharlal Nehru Pharmacity Parawad, Visakhapatnam – 531019, Andhra Pradesh, India
  • Unit 5, Plot No. 24, 24A and 24 B, (Denotified Area), APSEZ Atchutapuram Lalam, Koduru (V), Rambilli (M), Atchutapuram, Visakhapatnam – 531011, Andhra Pradesh, India

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Venkata Ramaraju Manthena

Designation :

Managing director

Address :

Plot No. 281, F/A Road, No. 10B, Jubilee Hills, Hyderabad – 500033, Telangana, India

Date of Birth/Age :

15.06.1946

Qualification :

Master of Science (Chemistry)

Date of Appointment :

29.09.2009

PAN No.:

AARPM1206D

DIN No.:

00085767

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24230TG1991PLC013162

VASUDHA ORGANICS LIMITED

04/09/1991

-

U24100TG1996PLC024189

SHRI RAM CHLOROCHEM LIMITED

30/10/2000

-

U01119TG2002PTC039159

VANAJA FARMS AND ESTATES PRIVATE LIMITED

26/09/2016

-

U01119TG2002PTC040117

EKADANTA FARMS AND ESTATES PRIVATE LIMITED

28/09/2016

-

U70102TG2003PLC041857

VASUDHA HOMES LIMITED

13/10/2003

-

U70102TG2002PTC039830

EKAVIRA FARMS AND ESTATES PRIVATE LIMITED

26/09/2016

-

U01119TG2006PTC048937

EKAGRA AGRO FARMS PVT LTD

26/09/2016

-

U45200TG2007PTC056651

VASISTHA INFRASTRUCTURE PRIVATE LIMITED

27/09/2016

-

U24100AP2010PLC070652

VEDA BIOFUEL LIMITED

30/12/2011

-

 

 

Name :

Mrs. Varalakshmi Mantena

Designation :

Director

Address :

Plot No.281 F/A Road No. 10b, Jubilee Hills Hyderabad 500033, Andhra Pradesh, India

Date of Birth/Age :

10.08.1949

Qualification :

Bachellor of Science (B Sc)

Date of Appointment :

26.02.2015

PAN No.:

ABIPM9053C

DIN No.:

00085857

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U65920TG1996PLC023172

V P C L FINANCE LIMITED

11/01/2008

-

U01119TG2006PTC049204

VAHINI AGRO FARMS PVT LTD

30/09/2006

-

U45209TG2008PTC058700

VISHNUPRIYA INFRASTRUCTURE PRIVATE LIMITED

29/09/2016

-

 

 

Name :

Mr. Ashok Srinivasa Raju Mantena

Designation :

Whole-Time Director

Address :

Flat No. 1201, A Block, Fortune Towers, Madhapur, Beside Petrol Bank, Hyderabad – 500081, Telangana, India

Date of Birth/Age :

26.03.1972

Qualification :

Master of Science (Chemical Engineering)

Date of Appointment :

24.06.1998

PAN No.:

AHWPM3791P

DIN No.:

00085896

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U45200TG2007PTC056641

VIJETHA BUILDERS PRIVATE LIMITED

27/09/2016

-

U45400TG2007PTC056694

OMSHAKTI BUILDERS PRIVATE LIMITED

28/09/2016

-

U45209TG2009PTC065672

SREEJA INFRASTRUCTURE PRIVATE LIMITED

15/02/2016

-

U45200TG2007PTC056651

VASISTHA INFRASTRUCTURE PRIVATE LIMITED

28/09/2012

-

U01119TG2006PTC049541

OMKARA RESORTS PRIVATE LIMITED

28/09/2016

-

U40107TG2013PTC091180

SARAYU CLEAN INFRA PRIVATE LIMITED

21/11/2013

-

U70102TG2003PLC041857

VASUDHA HOMES LIMITED

13/10/2003

-

U24100TG1996PLC024189

SHRI RAM CHLOROCHEM LIMITED

20/09/2014

-

U24230TG1991PLC013162

VASUDHA ORGANICS LIMITED

04/09/1991

-

U41000AP2016PLC103829

ATCHUTAPURAM EFFLUENT TREATMENT LIMITED

09/08/2016

-

 

 

Name :

Mr. Anand Manthena

Designation :

Whole-Time Director

Address :

8-2-293/82/A/667, Road No.33, Jubilee Hills, Hyderabad - 500033, Telangana, India

Date of Birth/Age :

10.06.1974

Qualification :

Master of Business Administration

Date of Appointment :

22.08.2011

PAN No.:

AAUPM0373L

DIN No.:

00085970

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24230TG1991PLC013162

VASUDHA ORGANICS LIMITED

20/09/2014

-

U24100TG1996PLC024189

SHRI RAM CHLOROCHEM LIMITED

28/09/2002

-

U70102TG2003PLC041857

VASUDHA HOMES LIMITED

13/10/2003

-

U70102TG2002PTC039830

EKAVIRA FARMS AND ESTATES PRIVATE LIMITED

26/09/2016

-

U01119TG2006PTC048937

EKAGRA AGRO FARMS PVT LTD

26/09/2016

-

U01119TG2006PTC049205

VALLABHA AGRO TECH PVT LTD

29/09/2016

-

U01122TG2006PTC049540

EKALAVYA FARMS AND RESORTS PRIVATE LIMITED

28/09/2016

-

 

 

Name :

Venkatanaga Mantena Madhusudhan Raju

Designation :

Whole Time Director

Address :

Plot No. 498, Bhagat Singh Nagar, ADJ to Vasanth Nagar, Kukatpally, Hyderabad – 500072, Telangana, India

Date of Birth/Age :

02.05.1976

Qualification :

Bachellor of Commerce

Date of Appointment :

19.07.2011

PAN No.:

ANQPM3013Q

DIN No.:

00685753

 

 

Name :

Mr. Venkata Surya Naga Vara Prasad Raju Mantena

Designation :

Whole-Time Director

Address :

Flat No.101, Nakshatra Castle, Prashanti Nagar, Kurmannapalem, Gajuwaka, Visakhapatnam - 530046, Andhra Pradesh, India

Date of Birth/Age :

10.08.1964

Qualification :

Bachellor of Commerce

Date of Appointment :

20.09.2012

PAN No.:

AOHPM1430M

DIN No.:

00686034

 

 

Name :

Mr. Jagadeeswaravarma Raju Vegesana

Designation :

Wholetime Director

Address :

Flat No.A 907, Nagarjuna Residency Telecom Nagar, Gachibowli

Date of Birth/Age :

10.08.1955

Qualification :

Master of Commerce (M Com)

Date of Appointment :

26.12.2006

PAN No.:

ABHPV6466F

DIN No.:

01125213

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24100TG1996PLC024189

SHRI RAM CHLOROCHEM LIMITED

28/09/2007

-

 

 

Name :

Mr. Venkata Rama Raju Gadiraju

Designation :

Director

Address :

2-2-23/22/15, Bagh Amberpet, Hyderabad – 500013, Telangana, India

Date of Birth/Age :

03.04.1939

Qualification :

Bachellor of Engineering (B E) (Mechanical)

Date of Appointment :

17.06.2013

PAN No.:

ACGPG3705Q

DIN No.:

01873163

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U28910TG1976PTC002025

DIAGRAM FORGINGS PVT LTD

26/04/1976

-

U31200TG1984PTC005131

DIAGRAM FABRICATORS PVT LTD

27/11/1984

-

U40100TG1995PLC021342

R R BIO-ENERGIES LIMITED

07/08/1995

-

U28999TG1995PTC020038

DIAGRAM FORGETOOLS PRIVATE LIMITED

18/04/1995

-

 

 

Name :

Mr. Venkata Raju Kalidindi

Designation :

Director

Address :

#G2, Parimala Pride, "C" Block, Aecs Layout, Kundalahalli, Bangalore - 560037, Karnataka, India

Date of Birth/Age :

08.06.1964

Qualification :

Bachellor of Technology (B Tech) (Civil Engineering)

Date of Appointment :

23.03.2009

PAN No.:

AHTPK6870G

DIN No.:

02568582

 

 

Name :

Mr. Karanam Aravinda Rao

Designation :

Additional Director

Address :

Plot No.8, Gurukula Patashala, Puppalaguda, Rajendranagar Ranga Reddy District-500089, Telangana, India

Date of Birth/Age :

06.06.1951

Date of Appointment :

23.01.2017

PAN No.:

AFAPK5858H

DIN No.:

07002205

 

Note:

No company exist for a Director:

·         Mr. Venkatachelam Samba Murthy Perinkolam

 

 

KEY EXECUTIVES

 

Name :

Mr. Jagadeeswaravarma Raju Vegesana

Designation :

Chief Finance Officer

Address :

Flat No. A 907, Nagarjuna Residency Telecom Nagar, Gachibowli Hyderabad-500032, Telangana, India

Date of Birth/Age :

10.08.1955

Qualification :

Master of Commerce (M Com)

Date of Appointment :

01.04.2014

PAN No.:

ABHPV6466F

 

 

Name :

Mr. Phani Chakravarthy Nadupalle

Designation :

Company Secretary

Address :

Plot No. 256, H. No. 9-222/1, Employees Colony Near Mallanna Temple, Yapral Secunderabad-500087, Telangana, India

Date of Appointment :

19.09.2016

PAN No.:

BDUPP0350E

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2016

 

SHAREHOLDING DETAILS FILE ATTACHED

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2016

 

Category

Percentage

Promoters (Individual/Hindu Undivided Family - Indian)

96.18

Public/Other than promoters (Individual/Hindu Undivided Family - Indian)

2.83

Public/Other than promoters (Bodies corporate)

0.99

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Active Pharmaceutical Ingredients and Pharma Intermediates. [Registered Activity and also confirmed by management]

 

 

Products :

Item Code No.

Product Description

29420090

Pentaprazole

29225024

Domperidone

29333990

Losartan Potassium

29333990

Loratidine

29029090

Fexofenadine

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

 

Countries :

  • European Country
  • United State of America
  • United Kingdom
  • Middle East
  • Far East Countries

 

 

Imports :

 

Products :

Raw Material

Countries :

  • China
  • Malaysia
  • European Country
  • Singapore

 

 

Terms :

 

Selling :

L/C, Cheque and Credit (30 / 90 Days)

 

 

Purchasing :

L/C, Cheque and Credit (30 / 90 Days)

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

End Users and Manufacturer

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

2000 (Approximately)

 

 

Bankers :

Bank Name

The Hongkong and Shanghai Banking Corporation Limited

Branch

6-3-1107 and 1108, Raj Bhavan Road, Somajiguda, Hyderabad – 500082, Telangana, India

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

Total Limit = INR 1250.000 Million

Account Operation

--

Remarks (If any)

--

 

 

Bank Name

HDFC Bank Limited

Branch

HDFC Bank House Senapati Bapat Marg, Lower Parel West, Mumbai - 400013, Maharashtra, India

Credit Facilities Enjoyed (If any)

Total Limit = INR 1250.000 Million

 

 

Bank Name

Citibank N.A

Branch

Queens Plaza, S P Road, Secunderabad - 500003, Telangana, India

Credit Facilities Enjoyed (If any)

Total Limit = INR 1250.000 Million

 

·         Export-Import Bank of India

Floor 21, Centre One Building, World Trade Centre, Cuffe Parade, Mumbai - 400006, Maharashtra, India

 

·         Standard Chartered Bank

G5, Ground Floor, Ashok Bhoopal Chambers, S P Road, Secunderabad - 500003, Andhra Pradesh, India

 

 

Facilities :

Secured Loan

31.03.2015

(INR In Million)

31.03.2014

(INR In Million)

Long-term Borrowings

 

 

Rupee term loans from banks

0.000

23.529

(Personal guarantees of Mr. M V Rama Raju, Chairman and Managing Director, Mr. M A S Raju, Director – Technical and Sri M Anand, Di r e c tor - Commercial)

 

 

Short-term borrowings

 

 

Loans repayable on demand from banks

815.553

784.072

(Personal guarantees of Sri M V Rama Raju, Chairman and Managing Director, Sri M A S Raju, Director – Technical and Sri M Anand, Director - Commercial.)

 

 

Total

815.553

807.601

 

Auditors :

 

Name :

Paturi and Associates

Chartered Accountants

Address :

G1, Jayaramakrishna Residency, Jaya Prakash Nagar, Yellareddyguda, Hyderabad – 500073, Telangana, India

Tel No.:

91-40-23746430

Mob No.:

91-9848882181

Email.:

paturiassociates@gmail.com

PAN N Income-tax PAN of auditor or auditor's firm :

AAQPP2545M

 

 

Secretarial Audit Report :

 

Name :

D.Hanumanta Raju and Company

Address :

B-13, F-1, P S Nagar, Vijaynagar Colony, Hyderabad – 500057, Telangana, India

PAN No.:

AAIFD5899E

 

 

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Related Parties :

·         Vasudha Organics Limited

U24230TG1991PLC013162

 

·         Shri Ram Chlorochem Limited

U24100TG1996PLC024189

 

 

CAPITAL STRUCTURE

 

As on 31.03.2015

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

35000000

Equity Shares

INR 10/- each

INR 350.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

35000000

Equity Shares

INR 10/- each

INR 350.000 Million

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

350.000

350.000

350.000

(b) Reserves & Surplus

2395.568

1888.244

1451.866

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2745.568

2238.244

1801.866

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

18.680

46.993

96.957

(b) Deferred tax liabilities (Net)

45.944

46.822

44.445

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

64.624

93.815

141.402

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

815.553

784.072

610.738

(b) Trade payables

311.695

434.261

235.231

(c) Other current liabilities

208.502

236.616

188.276

(d) Short-term provisions

10.531

8.712

2.064

Total Current Liabilities (4)

1346.281

1463.661

1036.309

 

 

 

 

TOTAL

4156.473

3795.720

2979.577

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1059.386

930.454

814.669

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

36.118

88.563

42.647

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

12.494

16.190

20.931

(e) Other Non-current assets

0.000

0.000

0.065

Total Non-Current Assets

1107.998

1035.207

878.312

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

1004.108

938.083

737.498

(c) Trade receivables

1582.790

1327.164

1014.254

(d) Cash and cash equivalents

216.833

287.053

157.622

(e) Short-term loans and advances

243.373

208.213

191.891

(f) Other current assets

1.371

0.000

0.000

Total Current Assets

3048.475

2760.513

2101.265

 

 

 

 

TOTAL

4156.473

3795.720

2979.577

 

 

PROFIT & LOSS ACCOUNT

 

 

Particulars

 

 

31.03.2017

31.03.2016

SALES TURNOVER

 

6010.000

5128.000

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

 

Not Available

561.000

 

Expected Sales (2017-2018) : INR 6500.000 Million

 

The above information has been parted by Mr. Kumar (Finance Manager)

 

 

PARTICULARS

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

Income

4625.098

4264.092

4029.260

 

Other Income

30.298

2.722

2.814

 

TOTAL

4655.396

4266.814

4032.074

 

 

 

 

Less

EXPENSES

 

 

 

Cost of Materials Consumed

2554.771

2529.560

2340.043

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(47.556)

(253.602)

(62.877)

 

Employees benefits expense

335.039

258.760

211.098

 

CSR Expenditure

846.221

851.763

762.859

 

Other expenses

10.688

0.000

0.000

 

TOTAL

3699.163

3386.481

3251.123

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

956.233

880.333

780.951

 

 

 

 

 

Less

FINANCIAL EXPENSES

82.689

58.945

36.597

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

873.544

821.388

744.354

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

104.617

92.155

86.224

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

768.927

729.233

658.130

 

 

 

 

 

Less

TAX

259.924

251.366

214.431

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

509.003

477.867

443.699

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

285.597

199.219

105.520

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Transfer to General Reserve

400.000

350.000

350.000

 

Tax expense/(benefit) of prior years

0.100

41.489

0.000

 

Transition Depreciation recognized

6.500

0.000

0.000

 

Total

406.600

391.489

350.000

 

 

 

 

 

 

Balance Carried to the B/S

388.000

285.597

199.219

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

F.O.B. Value of Exports

1557.929

1709.777

1327.946

 

TOTAL EARNINGS

1557.929

1709.777

1327.946

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

884.903

693.635

775.655

 

Packing Materials

0.000

0.000

0.405

 

components and spare parts

1.469

0.871

0.694

 

Capital Goods

5.684

6.001

3.959

 

TOTAL IMPORTS

892.056

700.507

780.713

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

15.54

13.65

12.68

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term debt

28.313

49.964

47.059

Cash generated from operations

470.570

629.334

443.077

Net cash flow from operating activity

211.477

345.504

218.994

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2015

31.03.2014

31.03.2013

Average Collection Days

(Sundry Debtors / Income * 365 Days)

124.91

113.60

91.88

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

2.92

3.21

3.97

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

44.53

62.66

36.69

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.95

0.94

1.06

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.87

0.86

0.91

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2015

31.03.2014

31.03.2013

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.34

0.41

0.40

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.31

0.39

0.42

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.49

0.65

0.58

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.40

0.46

0.48

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

11.56

14.93

21.34

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

((PAT / Sales) * 100)

%

11.01

11.21

11.01

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

12.25

12.59

14.89

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

18.54

21.35

24.62

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2015

31.03.2014

31.03.2013

Current Ratio

(Current Assets / Current Liabilities)

2.26

1.89

2.03

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

1.52

1.25

1.32

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.66

0.59

0.60

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

2.46

2.52

2.16

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

2.26

1.89

2.03

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

INR In Million

INR In Million

INR In Million

Share Capital

350.000

350.000

350.000

Reserves & Surplus

1451.866

1888.244

2395.568

Net worth

1801.866

2238.244

2745.568

 

 

 

 

Long Term borrowings

96.957

46.993

18.680

Short Term borrowings

610.738

784.072

815.553

Current Maturities of Long term debt

47.059

49.964

28.313

Total borrowings

754.754

881.029

862.546

Debt/Equity ratio

0.419

0.394

0.314

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

INR In Million

INR In Million

INR In Million

Sales

4029.260

4264.092

4625.098

 

 

5.828

8.466

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

INR In Million

INR In Million

INR In Million

Sales

4029.260

4264.092

4625.098

Profit

443.699

477.867

509.003

 

11.01%

11.21%

11.01%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

Yes

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last five years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last four years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

FINANCIAL HIGHLIGHTS

 

Gross Revenue of INR 5065.100 Million from operations was achieved during the financial year 2014-15, registering a growth of 9% over the previous year. Revenue from Export sales and Export incentives accounts for 42% of Gross Revenue from operations.

 

Profit Before Depreciation, Interest and Tax for the year was INR 956.200 Million and Profit Before Tax for the year was INR 768.900 Million, registering a growth of 4.50% and 5.44% respectively over the previous year. Profit After Tax for the year was INR 509.000 Million, registering a growth of 6.52% over the previous year.

 

 

REVIEW OF OPERATIONS:

 

Inspite of macroeconomic challenges and weak global economy, the company could sustain its margins and maintain its leadership position in its top five products

 

The Company obtained Certificate of Suitability (C.O.S) for eight products from European authorities, Mexican Good Manufacturing Practices (GMP) certificate for seven products, Korean Food and Drugs Administration (KFDA) approval for four products, Import Drug License for three products from Chinese authorities, registered two products with Japanese authorities and registered five products with Taiwan authorities as on the date of this report. In addition, the Company has also filed Drug Master Files (DMFs) for nine products with United States Food and Drugs Administration (USFDA), four products for C.O.S. certification, three products with Chinese authorities and four products with Taiwan authorities.

 

USFDA has completed 2nd surveillance audit of company’s Unit-I in May 2015 with zero 483 observations. The company is actively pursuing to become a sourcing partner for supplying Active Pharmaceutical Ingredients (APIs) to the reputed formulators in their Abbreviated New Drug Application (ANDA) filings. This will provide sustainable growth.

 

The company has completely repaid the Unit-III Term Loan (Availed from HDFC Bank) and has become Term Debt free as on the date of this report.

 

Now, the Company proposes to set up a manufacturing facility (Unit-IV) to convert its in-house APIs into pellets, which is a semi-finished formulation stage. The company has already purchased 3.32 acres of land in Jawaharlal Nehru Pharma City, Visakhapatnam and actively pursuing civil works. The capital outlay of the project is Rs.45 crores and will be entirely funded through internal accruals. In addition, the company is spending Rs.10 crores of routine capital expenditure during Financial Year 2015-16 to up-grade its existing three facilities, which will also be met from internal accruals.

 

 

OUTLOOK

 

The company will be launching three new APIs during the financial year 2015-16 and another three products are in the Research and Development (R & D) pipeline which will be launched in the financial year 2016-17. The company has also separated R & D into two departments namely, R & D and Process Development (PD). R & D carries out the process development for launching new products and PD engages in process development (improvement) of existing products. This will enable the company to address the challenges of launching new products for future growth and sustain the margins of existing products. The company’s new products, its increased supplies to the existing customers and more business in the regulated markets will drive the future growth of the company

 

The company expects to commence production in the pellets manufacturing facility (Unit-IV) by end of March, 2016 and completes the finishing works of the facility by end of first quarter of FY 2016-17. This will become another important step to move in the value chain, have innovative technology, retain existing customers, add new customers who are looking for APIs in the form of semi-finished formulations, provide value to the customers, control on costs and quality and improve profitability of the company.

 

Having acquired about 26 acres of land from APIIC Ltd., Special Projects Zone, Achutapuram, Visakhapatnam District, Andhra Pradesh at a cost of about INR 100.000 million, the company proposes to commence civil works during the first quarter of Financial Year 2016-17 for setting up APIs manufacturing facility. The estimated cost of the project and time line is being worked out. This project provides additional API production capacity and drive the future growth of the company.

 

 

UNSECURED LOAN

 

PARTICULARS

31.03.2015

(INR In Million)

31.03.2014

(INR In Million)

Long-Term Borrowings

 

 

Deferred payment liabilities

18.680

23.464

Total

18.680

23.464

 

 

INDEX OF CHARGES:

 

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G41514571

10526824

The Hongkong and Shanghai Banking Corporation Limited

16/10/2014

16/03/2017

-

300000000.0

6-3-1107 & 1108, Raj Bhavan Road,SomajigudaHyderabadTG500082IN

2

G12547030

10173480

HDFC BANK LIMITED

10/08/2009

30/07/2016

-

280000000.0

HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WMUMBAIMH400013IN

3

G10835742

10133649

Standard Chartered Bank

15/12/2008

30/07/2016

-

150000000.0

6-3-1090, TSR TOWERS, RAJ BHAVAN ROADSOMAJIGUDAHYDERABADTG500084IN

4

G09902883

10053700

KOTAK MAHINDRA BANK

09/05/2007

30/07/2016

-

170000000.0

27 B K C, C 27, "G" BLOCKBANDRA KURLA COMPLEX, BANDRA EASTMumbaiMH400051IN

5

G10947661

90123295

Citi Bank N.A.

13/01/2005

30/07/2016

-

350000000.0

Queens Plaza, S P RoadHYDERABADTG500003IN

6

C65824187

10242810

HDFC BANK LIMITED

18/08/2010

18/06/2013

24/09/2015

200000000.0

HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WMUMBAIMH400013IN

7

B58477282

10063714

EXPORT-IMPORT BANK OF INDIA

09/07/2007

16/06/2011

13/09/2012

270000000.0

FLOOR 21, CENTRE ONE BUILDINGWORLD TRADE CENTRE, CUFFE PARADEMUMBAIMH400006IN

8

A72156367

10052307

ICICI BANK LIMITED

09/05/2007

04/07/2008

04/11/2009

120000000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

9

A18304196

90122580

UNION BANK OF INDIA

14/03/1997

20/08/1999

19/06/2007

3000000.0

SOMAJIGUDA BRANCHHYDERABADAPIN

10

A18347484

90121061

UNION BANK OF INDIA

14/03/1997

20/08/1999

19/06/2007

4000000.0

SOMAJIGUDA BRANCHHYDERABADAPIN

 

 

CONTINGENT LIABILITIES:

 

Contingent Liabilities not provided for in respect of Irrevocable Documentary Letters of Credit of INR 75.857 Million (previous year INR 37.841 Million) and Bank Guarantees given by Bankers on behalf of the company of INR 0.446 Million (previous year INR 0.291 Million). 26. With reference to the search operation U/s 132 of Income Tax Act on the company on 11.11.2010, company has received assessment orders during the year for the block period of AY 2005-06 to AY 2010-11 and paid taxes there on of INR 41.489 and considered

 

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Factory building
  • Plant and equipment
  • Factory equipments
  • Furniture and fixtures
  • Vehicles
  • Motor vehicles
  • Office equipment
  • Computer equipments
  • Other equipments

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.61

UK Pound

1

INR 90.17

Euro

1

INR 78.94

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

VIV

 

 

Report Prepared by :

SUJ


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.